A Customized Registration for TULSA-PRO Ablation

Overview

About this study

This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Male.
  • ≥ 18 years old.
  • Candidate for TULSA-PRO treatment.
  • Willing and able to sign the Informed Consent form

Exclusion Criteria:

  • Individuals < 18 years old.

Eligibility last updated 12/3/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Chandler Dora, M.D.

Open for enrollment

Contact information:

Michel Tamayo Perez

TamayoPerez.Michel@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20526190

Mayo Clinic Footer